SG10201607176TA - Methods And Compositions For Treatment Of Retinal Degeneration - Google Patents

Methods And Compositions For Treatment Of Retinal Degeneration

Info

Publication number
SG10201607176TA
SG10201607176TA SG10201607176TA SG10201607176TA SG10201607176TA SG 10201607176T A SG10201607176T A SG 10201607176TA SG 10201607176T A SG10201607176T A SG 10201607176TA SG 10201607176T A SG10201607176T A SG 10201607176TA SG 10201607176T A SG10201607176T A SG 10201607176TA
Authority
SG
Singapore
Prior art keywords
compositions
treatment
methods
retinal degeneration
retinal
Prior art date
Application number
SG10201607176TA
Other languages
English (en)
Inventor
Casey C Case
Toru Kawanishi
Kuno Noriyuki
Original Assignee
Sanbio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanbio Inc filed Critical Sanbio Inc
Publication of SG10201607176TA publication Critical patent/SG10201607176TA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SG10201607176TA 2012-10-09 2013-03-13 Methods And Compositions For Treatment Of Retinal Degeneration SG10201607176TA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261711665P 2012-10-09 2012-10-09

Publications (1)

Publication Number Publication Date
SG10201607176TA true SG10201607176TA (en) 2016-10-28

Family

ID=48040427

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201502753YA SG11201502753YA (en) 2012-10-09 2013-03-13 Methods and compositions for treatment of retinal degeneration
SG10201607176TA SG10201607176TA (en) 2012-10-09 2013-03-13 Methods And Compositions For Treatment Of Retinal Degeneration

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG11201502753YA SG11201502753YA (en) 2012-10-09 2013-03-13 Methods and compositions for treatment of retinal degeneration

Country Status (11)

Country Link
US (2) US9326999B2 (zh)
EP (1) EP2906293B1 (zh)
JP (2) JP6267713B2 (zh)
KR (2) KR20150075082A (zh)
CN (1) CN104797264A (zh)
AU (2) AU2013330433B2 (zh)
CA (1) CA2885414C (zh)
HK (1) HK1208371A1 (zh)
IL (1) IL237772B (zh)
SG (2) SG11201502753YA (zh)
WO (1) WO2014058464A1 (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013330433B2 (en) 2012-10-09 2016-06-16 Sanbio, Inc. Methods and compositions for treatment of retinal degeneration
US10519237B2 (en) 2014-03-12 2019-12-31 Yeda Research And Development Co. Ltd Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
US10618963B2 (en) 2014-03-12 2020-04-14 Yeda Research And Development Co. Ltd Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
KR20200029627A (ko) 2014-03-12 2020-03-18 예다 리서치 앤드 디벨럽먼트 캄파니 리미티드 Cns의 질환 및 손상을 치료하기 위한 전신적 조절 t 세포 수준 또는 활성의 감소
PL3489016T3 (pl) 2014-07-31 2021-05-31 Unilin, Bv Sposób wytwarzania produktu w postaci okładziny podłogowej
WO2018102174A1 (en) * 2016-12-01 2018-06-07 Janssen Biotech, Inc. Treatment of retinal degeneration using progenitor cells
EP3548114A4 (en) 2016-12-28 2020-07-15 SanBio, Inc. CELL RELEASE SYSTEM AND METHOD FOR THE OPERATION THEREOF
EP3596111A4 (en) 2017-03-15 2021-01-06 The Regents of the University of California METHODS OF TREATMENT OF LYSOSOMAL STORAGE DISORDERS
CN107519491B (zh) * 2017-09-04 2020-08-25 无锡市人民医院 Copb2抑制剂的用途
WO2020210218A1 (en) * 2019-04-12 2020-10-15 The Regents Of The University Of California Methods for treating inherited eye defects

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002247847A1 (en) * 2001-04-09 2002-10-21 Lorantis Limited Therapeutic use and identification of modulators of a hedgehog signalling pathway or one of its target pathways
JP3886346B2 (ja) 2001-06-22 2007-02-28 サンバイオ，インコーポレイティド 骨髄間質細胞由来Ｓｃｈｗａｎｎ細胞を含む神経再生用医薬組成物
EP1409005A1 (en) * 2001-07-25 2004-04-21 Lorantis Limited Modulators of notch signalling for use in immunotherapy
ES2431518T3 (es) 2002-02-06 2013-11-26 Sanbio Inc. Método de diferenciación/inducción de células estromales de médula ósea en células nerviosas por transferencia del gen Notch
GB0300428D0 (en) * 2003-01-09 2003-02-05 Lorantis Ltd Medical treatment
WO2005100552A2 (en) 2004-04-12 2005-10-27 Sanbio Inc. Cells exhibiting neuronal progenitor cell characteristics
ES2436401T3 (es) 2005-03-07 2013-12-30 Sanbio, Inc. Uso de células precursoras neuronales para el tratamiento de lesiones del sistema nervioso central
KR20090109127A (ko) * 2007-02-12 2009-10-19 안트로제네시스 코포레이션 부착성 태반 줄기세포에서 유래한 간세포와 연골세포 및 ｃｄ34＋, ｃｄ45－ 태반 줄기세포가 농축된 세포군
WO2008102460A1 (en) 2007-02-23 2008-08-28 Sanbio Inc. Transplantation of bone marrow stromal cell-induced neural stem cells for promoting fuctional recovery after spinal cord injury
JP5662147B2 (ja) 2007-08-15 2015-01-28 サンバイオ，インコーポレイティド 神経変性を治療するための方法及び組成物
US10702554B2 (en) 2007-12-03 2020-07-07 Sanbio, Inc. Extracellular matrix from pluripotent cells
DK2222839T3 (en) 2007-12-03 2015-12-21 Sanbio Inc Methods and compositions for modulating differentiation of pluripotent cells
WO2009071659A1 (en) 2007-12-06 2009-06-11 INSERM (Institut National de la Santé et de la Recherche Médicale) Trophic factor for the treatment of retinal degenerative diseases
US10316288B2 (en) 2008-04-30 2019-06-11 Sanbio, Inc. Neural regenerating cells with alterations in DNA methylation
EP2308054B1 (en) 2008-07-01 2016-04-13 LSI Corporation Methods and apparatus for interfacing between a flash memory controller and a flash memory array
PL2307051T3 (pl) * 2008-07-08 2015-07-31 Oncomed Pharm Inc Środki wiążące i antagoniści Notch oraz sposoby ich zastosowania
US20110002897A1 (en) * 2009-06-11 2011-01-06 Burnham Institute For Medical Research Directed differentiation of stem cells
CN102858402B (zh) * 2010-02-26 2016-03-30 康奈尔大学 视网膜假体
PL2596119T3 (pl) * 2010-07-23 2021-12-06 Astellas Institute For Regenerative Medicine Sposoby wykrywania rzadkich subpopulacji komórek i kompozycje wysoko oczyszczonych komórek
US8883502B2 (en) * 2010-09-09 2014-11-11 The Regents Of The University Of California Expandable cell source of neuronal stem cell populations and methods for obtaining and using them
CA2832356C (en) 2011-04-06 2017-12-19 Sanbio, Inc. Methods and compositions for modulating peripheral immune function
US20120263681A1 (en) 2011-04-12 2012-10-18 Fujifilm Corporation Composition comprising cell and biocompatible polymer
CN103842498A (zh) 2011-08-19 2014-06-04 桑比欧公司 神经源性因子和胶质生成性因子及其测定
AU2013211934B2 (en) 2012-01-27 2017-09-14 Sanbio, Inc. Methods and compositions for modulating angiogenesis and vasculogenesis
CN104519891B (zh) 2012-05-16 2019-03-22 桑比欧公司 用于治疗创伤性脑损伤和用于调节神经原性细胞迁移的方法和组合物
AU2013330433B2 (en) 2012-10-09 2016-06-16 Sanbio, Inc. Methods and compositions for treatment of retinal degeneration
US20140219976A1 (en) 2012-10-09 2014-08-07 Sanbio, Inc. Methods and compositions for treatment of retinal degeneration

Also Published As

Publication number Publication date
KR101906756B1 (ko) 2018-12-05
KR20170133515A (ko) 2017-12-05
HK1208371A1 (zh) 2016-03-04
US9326999B2 (en) 2016-05-03
AU2013330433A1 (en) 2015-04-02
WO2014058464A1 (en) 2014-04-17
US20140099291A1 (en) 2014-04-10
KR20150075082A (ko) 2015-07-02
US9855299B2 (en) 2018-01-02
JP2015533122A (ja) 2015-11-19
AU2013330433B2 (en) 2016-06-16
IL237772A0 (en) 2015-05-31
JP6267713B2 (ja) 2018-01-24
EP2906293A1 (en) 2015-08-19
JP6297648B2 (ja) 2018-03-20
CA2885414A1 (en) 2014-04-17
JP2016210813A (ja) 2016-12-15
CA2885414C (en) 2018-05-01
SG11201502753YA (en) 2015-05-28
AU2016213752B2 (en) 2017-11-23
CN104797264A (zh) 2015-07-22
AU2016213752A1 (en) 2016-08-25
IL237772B (en) 2019-10-31
US20160271181A1 (en) 2016-09-22
EP2906293B1 (en) 2018-12-12

Similar Documents

Publication Publication Date Title
IL260585B (en) Preparations and methods for the treatment of diseases related to the retina of the eye
HK1210502A1 (zh) 用於治療遺傳性病狀的方法和組合物
HK1210968A1 (zh) 用於眼部疾病和病症的組合物和治療
HK1208371A1 (zh) 用於治療視網膜變性的方法和組合物
EP2771030A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF PROTEINOPATHIES
PT2776567T (pt) Composições e métodos para o tratamento de citomegalovírus
SG2014008080A (en) Methods of treatment of retinal degeneration diseases
EP2819687A4 (en) COMPOSITIONS AND METHODS FOR TREATING PERIPHERAL VASCULAR DISEASE
DK3292875T3 (en) Compositions and methods for treating diseases
EP2691529A4 (en) METHOD AND COMPOSITIONS FOR TREATING BRAIN DISEASES
PL2814463T3 (pl) Okulistyczne kompozycje farmaceutyczne i sposoby ich wytwarzania i stosowania
IL234606B (en) Innovative methods and compounds for the treatment of diseases
EP2755668A4 (en) COMPOSITIONS OF HYR1 AND TREATMENT PROCEDURES THEREWITH
EP2670243A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF GLAUCOMA
EP2879495A4 (en) COMPOSITIONS AND METHODS OF TREATING NEUROPSYCHOLOGICAL DEFICIENCIES
EP2928456A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
EP2800568A4 (en) COMPOSITIONS, USE METHOD AND TREATMENT METHOD THEREFOR
EP2825184A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF PAIN
EP3003341A4 (en) Compositions and methods for treatment of retinal degenerative diseases
AU2012902296A0 (en) Compositions for Therapy and Methods of Treatment